Background illustration for clinical trials search

Leukemia Clinical Trials

Browse 1,316 Leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

for
CLL / SLL, CLL (Chronic Lymphocytic Leukemia), CLL, Refractory,
Location: Bethesda MD, Skokie IL, Spokane WA, Las Vegas NV
Sponsor: Newave Pharmaceutical Inc

Sex: All

Age: 18+

Code: NCT07342478

Phase3, Recruiting

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

for
B Acute Lymphoblastic Leukemia
Location: Boston MA, Providence RI, New Haven CT, Lake Success NY,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18 - 39

Code: NCT03150693

Phase3, Recruiting

A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).

for
Chronic Leukemia Myelogenous
Location: New York NY
Sponsor: Pfizer

Sex: All

Age: 20+

Code: NCT06297161

Recruiting

Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity

for
Acute Lymphoblastic Leukemia, Obesity
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 18+

Code: NCT07228741

Phase2, Recruiting

High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)

for
Acute Myeloid Leukemia
Location: Iowa City IA
Sponsor: Kittika Poonsombudlert

Sex: All

Age: 18 - 70+

Code: NCT07177079

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies

for
Hodgkin Disease, CD30-Positive Diffuse Large B-Cell Lymphoma,
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18+

Code: NCT05544968

Phase1, Recruiting

Venetoclax Basket Trial for High Risk Hematologic Malignancies

for
Myelodysplastic Syndromes, de Novo,
Location: Boston MA, Atlanta GA, Chicago IL, Aurora CO,
Sponsor: Andrew E. Place, MD

Sex: All

Age: 1 - 40

Code: NCT05292664

Phase1, Recruiting

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

for
Lymphoma Diffuse Large B-cell, Leukemia and Lymphoma,
Location: Nashville TN
Sponsor: AvenCell Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07284433

Phase1, Phase2, Recruiting

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

for
Acute Promyelocytic Leukemia (APL),
Location: The Bronx NY, Baltimore MD, Charlottesville VA,
Sponsor: Quetzal Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07504458

Phase3, Recruiting

Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies

for
Myeloid Malignancy, Hematologic Malignancy,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18 - 70+

Code: NCT07044544

Phase1, Recruiting

Spiritual Care Intervention in Adult Patients Diagnosed With Acute Leukemia

for
Leukemia
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT07405424

Recruiting

CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL

for
Leukemia, Lymphoma
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT07294677

Phase1, Phase2, Recruiting

FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia

for
Acute Myeloid Leukemia, Myelodysplastic Syndrome
Location: The Bronx NY
Sponsor: Montefiore Medical Center

Sex: All

Age: 18+

Code: NCT07283094

Phase1, Recruiting

Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes

for
Acute Myeloid Leukemia, Myelodysplastic Syndrome
Location: New York NY, Houston TX
Sponsor: Remedy Plan, Inc.

Sex: All

Age: 18+

Code: NCT07107126

Phase1, Recruiting

Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant

for
Multiple Myeloma, Plasma Cell Leukemia
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT05405387

Phase2, Recruiting

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,
Location: Phoenix AZ, Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18 - 54

Code: NCT06918431

Phase2, Recruiting

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

for
Chronic Lymphocytic Leukemia
Location: Boston MA, Quebec, Sherbrooke, New York NY, Montreal,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07277231

Phase3, Recruiting

A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab

for
B-Cell ALL, B-Cell Acute Lymphoblastic Leukaemia,
Location: Little Rock AR, Springdale AR
Sponsor: Arkansas Children's Hospital Research Institute

Sex: All

Age: 1 - 23

Code: NCT07422337

Recruiting

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,
Location: Stony Brook NY, Lake Success NY, Manhasset NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03739814

Phase2, Recruiting

Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma

for
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT07224100

Phase2, Recruiting

What are clinical trials for leukemia?

Clinical trials for leukemia are research studies designed to evaluate new treatments, therapies, or diagnostic methods for different types of leukemia, a group of cancers that affect the blood and bone marrow. These trials aim to discover more effective ways to treat leukemia, manage its symptoms, and improve patient outcomes. They may involve testing new drugs, combinations of existing treatments, targeted therapies, immunotherapies, or novel approaches like gene therapy.

Why are leukemia clinical trials important?

Leukemia clinical trials are crucial because they drive advancements in treatment by testing new therapies, improving existing ones, and exploring novel approaches to manage and potentially cure the disease. These trials provide essential data on the safety and effectiveness of new treatments, which can lead to better outcomes and fewer side effects compared to current options.

Types of clinical trials for leukemia

Why participate in a leukemia clinical trial

Who can participate in a clinical trial for leukemia?

How to enroll in a leukemia clinical trial